Omega (AIM: ODX), the medical diagnostics company focused on CD4, food intolerance and allergy testing announces that it has signed a Memorandum of Understanding (“MOU”) with three other companies from across the UK, in conjunction with the University of Oxford to form the UK Rapid Test Consortium (“UK-RTC”) in order to jointly develop and manufacture a COVID-19 Point of Care antibody test as part of the Government’s five pillar national testing strategy for COVID-19.   Read more here: http://www.omegadiagnostics.com/Portals/0/RNS%20MOU%20on%20COVID-19%20Consortium.pdf